Latest On Cytosorbents Corporation (CTSO):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-03 09:18 EST | News | Cytosorbents Corporation (CTSO) Q1 2023 Earnings Call Transcript | N/A |  |
| 2023-05-02 21:22 EST | News | Cytosorbents GAAP EPS of -$0.17 misses by $0.02, revenue of $9.44M beats by $0.71M | N/A | |
| 2023-05-01 20:53 EST | News | Cytosorbents Q1 2023 Earnings Preview | N/A | |
| 2023-03-10 06:49 EST | News | Cytosorbents GAAP EPS of -$0.75 beats by $0.14, revenue of $29.36M misses by $4.69M | N/A | |
| 2023-03-10 06:49 EST | News | Cytosorbents Corporation (CTSO) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-01-31 14:20 EST | News | CytoSorbents guides Q4 revenue above estimates | N/A | |
| 2023-01-23 14:05 EST | News | CytoSorbents says Canada cleared pivotal study for anti-bleeding technology | N/A | |
| 2022-12-29 16:40 EST | News | Cytosorbents draws $5M debt financing; extends loan agreement | N/A | |
| 2022-12-21 20:25 EST | News | CytoSorbents receives recommendation from DSMB to continue trial of DrugSorb-ATR | N/A | |
| 2022-11-06 02:39 EST | News | CytoSorbents Corporation (CTSO) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-04 01:21 EST | News | Cytosorbents GAAP EPS of -$0.28 misses by $0.12, revenue of $8.1M misses by $0.42M | N/A | |
| 2022-11-03 07:35 EST | News | Cytosorbents Q3 2022 Earnings Preview | N/A | |
| 2022-11-02 15:48 EST | News | AMD, JD and BILI are among pre market gainers | N/A | |
| 2022-10-07 14:55 EST | News | CytoSorbents CFO to retire | N/A | |
| 2022-10-06 10:10 EST | News | CytoSorbents secures $4.3M contract by U.S. Department of Defense | N/A | |
| 2022-09-09 20:31 EST | News | CytoSorbents stock rises on US DoD contract to develop device for universal plasma | N/A | |
| 2022-08-24 02:39 EST | News | CytoSorbents gets reimbursement for CytoSorb in Turkey | N/A | |
| 2022-08-17 16:37 EST | News | CytoSorbents stock rises 10% as Israel approves coverage for CytoSorb system | N/A | |
| 2022-08-03 04:46 EST | News | Cytosorbents GAAP EPS of -$0.25 misses by $0.13, revenue of $8.5M misses by $1.06M | N/A | |
| 2022-08-03 04:46 EST | News | Cytosorbents Corporation's (CTSO) CEO Phillip Chan on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-02 00:00 EST | News | Cytosorbents Q2 2022 Earnings Preview | N/A | |
| 2022-06-10 17:48 EST | News | Cytosorbents (CTSO) 2022 Annual Shareholders Meeting - Slideshow | N/A | |
| 2022-05-07 18:59 EST | News | Cytosorbents Corporation (CTSO) CEO Phillip Chan on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-06 01:40 EST | News | Cytosorbents Corporation 2022 Q1 - Results - Earnings Call Presentation | N/A | |
| 2022-05-05 01:52 EST | News | CytoSorbents stock slumps as Q1 revenue falls 18% Y/Y | N/A | |
| 2022-05-04 05:19 EST | News | Cytosorbents GAAP EPS of -$0.21 misses by $0.06, revenue of $8.69M misses by $1.32M | N/A | |
| 2022-05-02 18:32 EST | News | Cytosorbents Q1 2022 Earnings Preview | N/A | |
| 2022-04-29 23:11 EST | News | CytoSorbents stock rises as enrollment begins in trial of DrugSorb-ATR system | N/A | |
| 2022-03-09 05:19 EST | News | Cytosorbents reports Q4 results | N/A | |
| 2022-03-09 05:19 EST | News | Cytosorbents Corporation (CTSO) CEO Phillip Chan on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-07 18:11 EST | News | Cytosorbents Q4 2021 Earnings Preview | N/A | |
| 2022-02-25 06:37 EST | News | Cytosorbents (CTSO) Presents At Annual SVB Leerink Global Health Conference | N/A | |
| 2022-02-02 00:51 EST | News | CytoSorbents says patient enrollment begins in PROCYSS trial of CYtoSorb for septic shock | N/A | |
| 2022-01-18 19:33 EST | News | CytoSorbents jumps 1.86% on prelim FY21 and Q4 revenue above the consensus | N/A | |
| 2021-11-07 12:12 EST | News | CytoSorbents Corporation (CTSO) CEO Phillip Chan on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-05 03:59 EST | News | Cytosorbents EPS misses by $0.03, beats on revenue | N/A | |
| 2021-11-04 06:53 EST | News | Cytosorbents Q3 2021 Earnings Preview | N/A | |
| 2021-10-21 03:30 EST | News | CytoSorbents says use of CytoSorb safe in patients with endocarditis | N/A | |
| 2021-10-19 08:19 EST | News | Warning: CTSO is at high risk of performing badly | N/A | |
| 2021-10-14 16:42 EST | News | CytoSorbents gets enrollment underway in DrugSorb-ATR STAR–T trial | N/A | |
| 2021-10-12 22:57 EST | News | CytoSorbents' Q3 prelim miss erases gains on FDA exemption | N/A | |
| 2021-10-08 05:53 EST | News | Cytosorbents: Endocarditis Trial Failed To Remove Risk In Heart Surgery Patients | N/A | |
| 2021-09-10 19:22 EST | News | CytoSorbents files IDE for U.S. trial on apixaban/rivaroxaban removal during cardiothoracic surgery | N/A | |
| 2021-09-01 21:46 EST | News | CytoSorbents presents CTC multicenter registry results in COVID-19 at ISICEM 2021 | N/A | |
| 2021-08-12 15:12 EST | News | CytoSorbents stock jumps 18% on second FDA Breakthrough Device tag for DrugSorb-ATR system | N/A | |
| 2021-08-04 05:24 EST | News | Cytosorbents EPS misses by $0.06, beats on revenue | N/A | |
| 2021-08-04 05:23 EST | News | CytoSorbents Corporation (CTSO) CEO Phillip Chan on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-21 03:24 EST | News | CytoSorbents' CytoSorb blood purification now available in Singapore | N/A | |
| 2021-07-21 02:43 EST | News | CytoSorbents cleared to start pivotal trial for antithrombotic removal system | N/A | |
| 2021-05-05 14:17 EST | News | CytoSorbents Corporation (CTSO) CEO Phillip Chan on Q1 2021 Results - Earnings Call Transcript | N/A | |
About Cytosorbents Corporation (CTSO):
Cytosorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention and treatment of post-operative complications of cardiopulmonary bypass surgery, and maintaining or improving the quality of solid organs harvested from donors for organ transplant. The company also develops VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals; CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, as well as removal of anti-A and anti-B blood group antibodies from fresh whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it is involved in the development of BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; and DrugSorb, a device to remove toxic chemicals from the blood. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is based in Monmouth Junction, New Jersey.
General
- Name Cytosorbents Corporation
- Symbol CTSO
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Full Time Employees 195
- Last Split Factor1:25
- Last Split Date2014-12-05
- Fiscal Year EndDecember
- IPO Date2013-11-07
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Equipment
- Web URLhttp://www.cytosorbents.com
View More
Valuation
- Forward PE 31.85
- Price/Sales (Trailing 12 Mt.) 8.51
- Price/Book (Most Recent Quarter) 4.91
- Enterprise Value Revenue 7.77
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.16
- Next Year EPS Estimate $0.04
- Next Quarter EPS Estimate $0.01
- Profit Margin -19%
- Operating Margin -25%
- Return on Assets -11%
- Return on Equity -19%
- Revenue 41 million
- Earnings Per Share -$0.53
- Revenue Per Share $1.06
- Gross Profit 29.95 million
- Quarterly Earnings Growth 60.9%
View More
Highlights
- Market Capitalization 375.53 million
- EBITDA -15662669
- Analyst Target Price $14.75
- Book Value Per Share $1.83
View More
Share Statistics
- Shares Outstanding 43.26 million
- Shares Float 39.65 million
- % Held by Insiders 839%
- % Held by Institutions 40.73%
- Shares Short 2.43 million
- Shares Short Prior Month 2.44 million
- Short Ratio 5.89
- Short % of Float 6%
- Short % of Shares Outstanding 6%
View More
Technicals
- Beta 0.15
- 52 Week High $11.74
- 52 Week Low $4.06
- 50 Day Moving Average 10.08
- 200 Day Moving Average 8.81
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Cytosorbents Corporation (CTSO) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Cytosorbents Corporation (CTSO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-09 | $N/A | -$0.01 | -$0.04 | 73.89% |
| 2020-09-30 | 2020-11-04 | $N/A | -$0.02 | -$0.10 | 78.95% |
| 2020-06-30 | 2020-08-04 | $N/A | -$0.08 | -$0.09 | 8.57% |
| 2020-03-31 | 2020-05-05 | $8.71 million | -$0.10 | -$0.15 | 33.33% |
| 2019-12-31 | 2020-03-05 | $7.43 million | -$0.13 | -$0.16 | 18.75% |
| 2019-09-30 | 2019-11-05 | $6.1 million | -$0.21 | -$0.14 | -52.73% |
| 2019-06-30 | 2019-08-06 | $6.23 million | -$0.11 | -$0.15 | 24.14% |
| 2019-03-31 | 2019-05-07 | $5.19 million | -$0.15 | -$0.18 | 16.67% |
| 2018-12-31 | 2019-03-07 | $6.08 million | -$0.17 | -$0.13 | -33.33% |
| 2018-09-30 | 2018-11-06 | $5.74 million | -$0.10 | -$0.14 | 27.27% |
| 2018-06-30 | 2018-08-02 | $5.76 million | -$0.19 | -$0.14 | -40.74% |
| 2018-03-31 | 2018-05-08 | $4.92 million | -$0.10 | -$0.14 | 25.93% |
| 2017-12-31 | 2018-03-08 | $4.65 million | -$0.12 | -$0.10 | -20% |
| 2017-09-30 | 2017-11-09 | $3.82 million | -$0.07 | -$0.07 | 3.45% |
| 2017-06-30 | 2017-08-07 | $3.57 million | -$0.04 | -$0.06 | 35.48% |
| 2017-03-31 | 2017-05-08 | $3.11 million | -$0.05 | -$0.10 | 51.22% |
| 2016-12-31 | 2017-03-03 | $3.08 million | -$0.16 | -$0.10 | -68.42% |
| 2016-09-30 | 2016-11-07 | $2.41 million | -$0.11 | -$0.11 | 2.22% |
| 2016-06-30 | 2016-08-09 | $2.22 million | -$0.12 | -$0.10 | -26.32% |
| 2016-03-31 | 2016-05-09 | $1.81 million | -$0.08 | -$0.10 | 15.79% |
| 2015-12-31 | 2016-03-09 | $1.76 million | -$0.08 | -$0.09 | 5.88% |
| 2015-09-30 | 2015-11-13 | $1.34 million | -$0.11 | -$0.10 | -10% |
| 2015-06-30 | 2015-08-13 | $964000 | $0.05 | -$0.11 | 145.45% |
| 2015-03-31 | 2015-05-11 | $723000 | -$0.19 | -$0.11 | -72.73% |
| 2014-12-31 | 2015-03-31 | $874000 | -$0.37 | -$0.17 | -117.65% |
| 2014-09-30 | 2014-11-12 | $1.16 million | -$0.22 | -$0.17 | -29.41% |
| 2014-06-30 | 2014-08-12 | $1.03 million | -$0.27 | -$0.12 | -125% |
| 2014-03-31 | 2014-05-15 | $1.06 million | -$0.20 | ||
| 2013-12-31 | 2014-03-31 | $879000 | -$0.25 | -$0.25 | 0% |
| 2013-09-30 | 2013-11-06 | $881000 | -$0.25 | -$0.25 | 0% |
| 2013-06-30 | 2013-08-14 | $292000 | -$0.25 | -$0.25 | 0% |
| 2013-03-31 | 2013-04-03 | $371000 | -$0.25 | -$0.25 | 0% |
| 2012-09-30 | 2012-11-21 | $605000 | -$0.25 | -$0.25 | 0% |
| 2012-06-30 | 2012-08-13 | $84000 | -$0.25 | -$0.25 | 0% |
| 2012-03-31 | 2012-05-30 | $50000 | -$0.29 | ||
| 2011-12-31 | 2012-02-29 | $36000 | -$0.30 | ||
| 2011-09-30 | 2011-09-30 | $N/A | -$0.37 | ||
| 2011-06-30 | 2011-06-30 | $N/A | -$0.35 | ||
| 2011-03-31 | 2011-03-31 | $N/A | -$0.37 | ||
| 2010-12-31 | 2010-12-31 | $N/A | -$0.27 | ||
| 2010-09-30 | 2010-09-30 | $N/A | -$0.28 | ||
| 2010-06-30 | 2010-06-30 | $N/A | -$0.29 | ||
| 2010-03-31 | 2010-03-31 | $N/A | -$0.60 | ||
| 2009-12-31 | 2009-12-31 | $N/A | -$0.28 | ||
| 2009-09-30 | 2009-09-30 | $N/A | -$0.60 | ||
| 2009-06-30 | 2009-06-30 | $N/A | -$0.71 | ||
| 2009-03-31 | 2009-03-31 | $N/A | -$0.80 | ||
| 2008-12-31 | 2008-12-31 | -$1.00 | |||
| 2008-09-30 | 2008-09-30 | -$1.01 | |||
| 2008-06-30 | 2008-06-30 | -$1.23 | |||
| 2008-03-31 | 2008-03-31 | -$0.85 | |||
| 2007-09-30 | 2007-09-30 | -$0.78 | |||
| 2007-06-30 | 2007-06-30 | -$0.91 | |||
| 2007-03-31 | 2007-03-31 | -$1.66 | |||
| 2006-12-31 | 2006-12-31 | -$1.50 | |||
| 2006-09-30 | 2006-09-30 | -$1.08 |
Cytosorbents Corporation (CTSO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | 2.69 million | N/A | N/A | 1.97 million | 3.56 million |
| Income Before Tax | -1.8 million | N/A | N/A | -3.45 million | -5.04 million |
| Selling General Administrative | 9.38 million | N/A | N/A | 6.84 million | 7.21 million |
| Gross Profit | 9.43 million | N/A | N/A | 6.32 million | 5.34 million |
| Ebit | -1.44 million | N/A | N/A | -2.97 million | -5.43 million |
| Operating Income | -2.63 million | N/A | N/A | -2.48 million | -5.43 million |
| Income Tax Expense | -1.13 million | N/A | N/A | N/A | -1.09 million |
| Total Revenue | N/A | N/A | N/A | 8.71 million | 7.43 million |
| Cost of Revenue | 2.53 million | N/A | N/A | 2.38 million | 2.09 million |
| Total Other Income Expense Net | N/A | N/A | N/A | -668488 | 389531 |
| Net Income From Continuing Operations | -677724 | N/A | N/A | -3.45 million | -3.95 million |
| Net Income Applicable to Common Shares | -677724 | -839729 | -2.87 million | -3.45 million | -3.95 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | -508562 | N/A | N/A |
| Change to Liabilities | -909820 | 1.45 million | -1.06 million | 1.83 million | -250381 |
| Total Cash Flow from Investing Activities | -404162 | -497358 | -508562 | -403223 | -315364 |
| Net Borrowings | N/A | N/A | N/A | N/A | 5 million |
| Total Cash Flow from Financial Activities | N/A | N/A | 17.88 million | 772774 | 5.22 million |
| Change to Operating Activities | -34406 | 1.05 million | 87107 | -910260 | -225305 |
| Change in Cash | N/A | N/A | 14.16 million | -3.75 million | -363618 |
| Total Cash from Operating Activities | -3.28 million | 1.94 million | -3.21 million | -4.12 million | -5.21 million |
| Depreciation | N/A | N/A | 181368 | 167417 | 138745 |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | 134270 | -320370 | -292988 |
| Change to Account Receivables | N/A | N/A | -1.02 million | -1.05 million | -117764 |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | 87881 | -92093 |
| Change to Net Income | 52375 | 428687 | 1.88 million | 73178 | 2.39 million |
| Capital Expenditures | N/A | N/A | 508562 | 140754 | 126369 |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 10.73 million | N/A | N/A | 22.91 million | 23.96 million |
| Total Stockholder Equity | 79.22 million | N/A | N/A | 21.31 million | 3.42 million |
| Other Current Liabilities | 1.03 million | N/A | N/A | N/A | N/A |
| Total Assets | 89.95 million | N/A | N/A | 44.23 million | 27.38 million |
| Common Stock | 43222 | 43176 | 36812 | 36130 | 32616 |
| Other Current Assets | 3.2 million | N/A | N/A | N/A | N/A |
| Retained Earnings | -196.63 million | -195.95 million | -195.11 million | -192.24 million | -188.79 million |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | 4.27 million | 4.13 million | 3.73 million | 3.48 million |
| Cash | 71.42 million | N/A | N/A | 26.39 million | 12.23 million |
| Total Current Liabilities | 10.15 million | 17.36 million | N/A | 11.46 million | 9.94 million |
| Other Stockholder Equity | -1.73 million | -517302 | 530447 | 1.14 million | 525978 |
| Property, Plant & Equipment | 2.12 million | 3.21 million | 3.18 million | 2.96 million | 3 million |
| Total Current Assets | 82.45 million | 96.8 million | N/A | 37.53 million | 20.9 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 79.22 million | 80.23 million | 24.32 million | 21.31 million | 3.42 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | 10.92 million | 13.39 million |
| Inventory | 2.67 million | 2.02 million | N/A | 1.97 million | 2.11 million |
| Accounts Payable | 9.71 million | 2.39 million | N/A | 1.77 million | 2.04 million |
Cytosorbents Corporation (CTSO) Chart:
Cytosorbents Corporation (CTSO) News:
Below you will find a list of latest news for Cytosorbents Corporation (CTSO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Cytosorbents Corporation (CTSO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 0.01 | CALL | 0 | 554 | 194.88 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0.05 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0.96 | PUT | 0 | 11 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 643.68 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 917.34 | TRUE | 0 | 0 |
| 2024-08-16 | 2.5 | 0.01 | CALL | 0 | 106 | 97.29 | FALSE | 0 | 0 |
| 2024-08-16 | 5 | 0.2 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 2.5 | 1.55 | PUT | 0 | 6 | 811.86 | TRUE | 0 | 0 |
| 2024-08-16 | 5 | 0 | PUT | 0 | 0 | 234.16 | TRUE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | PUT | 0 | 0 | 561.19 | TRUE | 0 | 0 |
| 2024-11-15 | 2.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 2.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-11-15 | 5 | 0 | PUT | 0 | 0 | 311.9 | TRUE | 0 | 0 |
| 2024-11-15 | 7.5 | 0 | PUT | 0 | 0 | 325.55 | TRUE | 0 | 0 |
Latest CTSO Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 100 | $2.18 |
| Jun 13, 2022 7:59 PM EST | 5 | $2.19 |
| Jun 13, 2022 7:59 PM EST | 25 | $2.18 |
| Jun 13, 2022 7:59 PM EST | 1 | $2.18 |
| Jun 13, 2022 7:59 PM EST | 15 | $2.19 |
Cytosorbents Corporation (CTSO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920076935/0001104659-20-076935-index.htm |
| 2018-08-01 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1175151/000000000018023795/0000000000-18-023795-index.htm |
| 2019-02-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1175151/000021545719006839/0000215457-19-006839-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1175151/000083423720005442/0000834237-20-005442-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1175151/000110465919060053/0001104659-19-060053-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465919060134/0001104659-19-060134-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465919060592/0001104659-19-060592-index.htm |
| 2019-11-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465919066813/0001104659-19-066813-index.htm |
| 2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465919067732/0001104659-19-067732-index.htm |
| 2019-12-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465919070448/0001104659-19-070448-index.htm |
| 2019-12-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465919071352/0001104659-19-071352-index.htm |
| 2019-12-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465919072196/0001104659-19-072196-index.htm |
| 2020-01-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920000438/0001104659-20-000438-index.htm |
| 2020-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920003914/0001104659-20-003914-index.htm |
| 2020-03-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920028647/0001104659-20-028647-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465920028648/0001104659-20-028648-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465920028650/0001104659-20-028650-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465920028652/0001104659-20-028652-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465920028654/0001104659-20-028654-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465920028655/0001104659-20-028655-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465920028656/0001104659-20-028656-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465920028657/0001104659-20-028657-index.htm |
| 2020-03-05 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1175151/000110465920029712/0001104659-20-029712-index.htm |
| 2020-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920029779/0001104659-20-029779-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465920032715/0001104659-20-032715-index.htm |
| 2020-04-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920047709/0001104659-20-047709-index.htm |
| 2020-04-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920047893/0001104659-20-047893-index.htm |
| 2020-04-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920048762/0001104659-20-048762-index.htm |
| 2020-04-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1175151/000110465920048764/0001104659-20-048764-index.htm |
| 2020-04-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920048772/0001104659-20-048772-index.htm |
| 2020-04-20 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1175151/000110465920048787/0001104659-20-048787-index.htm |
| 2020-04-21 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1175151/000110465920048793/0001104659-20-048793-index.htm |
| 2020-04-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920051686/0001104659-20-051686-index.htm |
| 2020-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465920053381/0001104659-20-053381-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920054445/0001104659-20-054445-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920054447/0001104659-20-054447-index.htm |
| 2020-05-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920056314/0001104659-20-056314-index.htm |
| 2020-05-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1175151/000110465920056867/0001104659-20-056867-index.htm |
| 2020-05-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465920056874/0001104659-20-056874-index.htm |
| 2020-05-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465920056881/0001104659-20-056881-index.htm |
| 2020-05-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920056970/0001104659-20-056970-index.htm |
| 2020-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465920058217/0001104659-20-058217-index.htm |
| 2020-05-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465920058219/0001104659-20-058219-index.htm |
| 2020-05-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920060203/0001104659-20-060203-index.htm |
| 2020-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920069510/0001104659-20-069510-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920072434/0001104659-20-072434-index.htm |
| 2020-06-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920076935/0001104659-20-076935-index.htm |
| 2020-07-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920084873/0001104659-20-084873-index.htm |
| 2020-07-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1175151/000110465920084894/0001104659-20-084894-index.htm |
| 2020-07-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920085360/0001104659-20-085360-index.htm |
| 2020-07-22 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1175151/000110465920085361/0001104659-20-085361-index.htm |
| 2020-07-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920085697/0001104659-20-085697-index.htm |
| 2020-07-22 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1175151/000110465920085698/0001104659-20-085698-index.htm |
| 2020-07-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920086431/0001104659-20-086431-index.htm |
| 2020-08-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1175151/000110465920090287/0001104659-20-090287-index.htm |
| 2020-08-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465920090308/0001104659-20-090308-index.htm |
| 2020-08-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920090345/0001104659-20-090345-index.htm |
| 2020-08-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000110465920097228/0001104659-20-097228-index.htm |
| 2020-11-04 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1175151/000110465920121349/0001104659-20-121349-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000110465920121457/0001104659-20-121457-index.htm |
| 2018-05-22 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1175151/000114420418030227/0001144204-18-030227-index.htm |
| 2018-05-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420418030585/0001144204-18-030585-index.htm |
| 2018-06-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420418033342/0001144204-18-033342-index.htm |
| 2018-06-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420418033465/0001144204-18-033465-index.htm |
| 2018-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420418034157/0001144204-18-034157-index.htm |
| 2018-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420418034161/0001144204-18-034161-index.htm |
| 2018-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420418034653/0001144204-18-034653-index.htm |
| 2018-06-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420418036585/0001144204-18-036585-index.htm |
| 2018-07-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420418037797/0001144204-18-037797-index.htm |
| 2018-07-26 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418040206/0001144204-18-040206-index.htm |
| 2018-07-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420418040208/0001144204-18-040208-index.htm |
| 2018-08-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1175151/000114420418041671/0001144204-18-041671-index.htm |
| 2018-08-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420418041930/0001144204-18-041930-index.htm |
| 2018-08-03 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418041955/0001144204-18-041955-index.htm |
| 2018-08-03 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1175151/000114420418041957/0001144204-18-041957-index.htm |
| 2018-08-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420418042169/0001144204-18-042169-index.htm |
| 2018-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420418042396/0001144204-18-042396-index.htm |
| 2018-08-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420418046276/0001144204-18-046276-index.htm |
| 2018-08-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420418047336/0001144204-18-047336-index.htm |
| 2018-08-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420418047340/0001144204-18-047340-index.htm |
| 2018-08-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420418047558/0001144204-18-047558-index.htm |
| 2018-08-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420418047656/0001144204-18-047656-index.htm |
| 2018-09-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420418048704/0001144204-18-048704-index.htm |
| 2018-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1175151/000114420418057624/0001144204-18-057624-index.htm |
| 2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420418058036/0001144204-18-058036-index.htm |
| 2018-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420418064025/0001144204-18-064025-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420419000926/0001144204-19-000926-index.htm |
| 2019-01-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420419002623/0001144204-19-002623-index.htm |
| 2019-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420419005023/0001144204-19-005023-index.htm |
| 2019-02-14 | 5 | Annual statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419008362/0001144204-19-008362-index.htm |
| 2019-03-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420419012616/0001144204-19-012616-index.htm |
| 2019-03-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419012634/0001144204-19-012634-index.htm |
| 2019-03-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419012635/0001144204-19-012635-index.htm |
| 2019-03-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419012636/0001144204-19-012636-index.htm |
| 2019-03-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419012637/0001144204-19-012637-index.htm |
| 2019-03-07 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1175151/000114420419012774/0001144204-19-012774-index.htm |
| 2019-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420419013747/0001144204-19-013747-index.htm |
| 2019-03-29 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419016966/0001144204-19-016966-index.htm |
| 2019-04-05 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1175151/000114420419018460/0001144204-19-018460-index.htm |
| 2019-04-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1175151/000114420419020456/0001144204-19-020456-index.htm |
| 2019-04-22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1175151/000114420419020458/0001144204-19-020458-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1175151/000114420419024246/0001144204-19-024246-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420419024330/0001144204-19-024330-index.htm |
| 2019-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419025962/0001144204-19-025962-index.htm |
| 2019-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420419029770/0001144204-19-029770-index.htm |
| 2019-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420419029797/0001144204-19-029797-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419030586/0001144204-19-030586-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419030603/0001144204-19-030603-index.htm |
| 2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420419030840/0001144204-19-030840-index.htm |
| 2019-07-09 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1175151/000114420419034168/0001144204-19-034168-index.htm |
| 2019-07-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420419034169/0001144204-19-034169-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419035836/0001144204-19-035836-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419035837/0001144204-19-035837-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419035838/0001144204-19-035838-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419035839/0001144204-19-035839-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419035840/0001144204-19-035840-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419035841/0001144204-19-035841-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419035842/0001144204-19-035842-index.htm |
| 2019-07-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419035843/0001144204-19-035843-index.htm |
| 2019-07-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420419036249/0001144204-19-036249-index.htm |
| 2019-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420419037670/0001144204-19-037670-index.htm |
| 2019-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420419037679/0001144204-19-037679-index.htm |
| 2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1175151/000114420419037883/0001144204-19-037883-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420419037900/0001144204-19-037900-index.htm |
| 2019-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419039650/0001144204-19-039650-index.htm |
| 2019-08-16 | 3/A | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419040379/0001144204-19-040379-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419040380/0001144204-19-040380-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419040420/0001144204-19-040420-index.htm |
| 2019-08-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419040422/0001144204-19-040422-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1175151/000114420419040629/0001144204-19-040629-index.htm |
| 2019-08-26 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1175151/000114420419041664/0001144204-19-041664-index.htm |
| 2019-09-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420419044743/0001144204-19-044743-index.htm |
| 2019-09-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1175151/000114420419045064/0001144204-19-045064-index.htm |
| 2018-08-07 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1175151/999999999518002029/9999999995-18-002029-index.htm |
| 2019-03-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1175151/999999999719001434/9999999997-19-001434-index.htm |
Cytosorbents Corporation (CTSO) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cytosorbents Corporation (CTSO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 839%Institutional Ownership: 4073%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-08-30 | Al Kraus | Director | Sell | 26,000.00 | 14.47 | 376,282.40 | 125,046.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418047656/0001144204-18-047656-index.htm |
| 2018-08-30 | Al Kraus | Director | Buy | 8,000.00 | 2.10 | 16,800.00 | 133,046.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418047656/0001144204-18-047656-index.htm |
| 2019-08-09 | KATHLEEN P. BLOCH | Chief Financial Officer | Buy | 1,500.00 | 5.52 | 8,273.40 | 13,500.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420419039650/0001144204-19-039650-index.htm |
| 2020-04-12 | Efthymios Deliargyris | Chief Medical Officer | Buy | 140,000.00 | 140,000.00 | https://www.sec.gov/Archives/edgar/data/1175151/000110465920056881/0001104659-20-056881-index.htm | ||
| 2019-07-22 | Eric R. Mortensen | Chief Medical Officer | Buy | 12,200.00 | 145,612.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420419035841/0001144204-19-035841-index.htm | ||
| 2019-08-14 | Eric R. Mortensen | Chief Medical Officer | Buy | 5,000.00 | 4.50 | 22,500.00 | 148,932.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420419040380/0001144204-19-040380-index.htm |
| 2018-08-30 | Al Kraus | Director | Buy | 18,000.00 | 4.20 | 75,600.00 | 151,046.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418047656/0001144204-18-047656-index.htm |
| 2019-08-16 | KATHLEEN P. BLOCH | Chief Financial Officer | Buy | 6,500.00 | 4.83 | 31,395.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420419040422/0001144204-19-040422-index.htm |
| 2019-11-26 | KATHLEEN P. BLOCH | Chief Financial Officer | Buy | 1,000.00 | 4.27 | 4,270.20 | 21,000.00 | https://www.sec.gov/Archives/edgar/data/1175151/000110465919067732/0001104659-19-067732-index.htm |
| 2019-03-04 | KATHLEEN P. BLOCH | Chief Financial Officer | Buy | 4,070.00 | 242,725.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420419012635/0001144204-19-012635-index.htm | ||
| 2018-08-03 | KATHLEEN P. BLOCH | Chief Financial Officer | Sell | 3,600.00 | 12.15 | 43,743.60 | 250,004.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418042396/0001144204-18-042396-index.htm |
| 2018-08-28 | KATHLEEN P. BLOCH | Chief Financial Officer | Sell | 10,000.00 | 13.50 | 135,000.00 | 250,004.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418047336/0001144204-18-047336-index.htm |
| 2019-06-07 | KATHLEEN P. BLOCH | Chief Financial Officer | Buy | 10,000.00 | 5.60 | 56,000.00 | 252,725.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420419030603/0001144204-19-030603-index.htm |
| 2018-08-03 | KATHLEEN P. BLOCH | Chief Financial Officer | Sell | 6,200.00 | 12.75 | 79,050.00 | 253,604.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418042396/0001144204-18-042396-index.htm |
| 2018-08-03 | KATHLEEN P. BLOCH | Chief Financial Officer | Sell | 200.00 | 12.85 | 2,570.00 | 259,804.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418042396/0001144204-18-042396-index.htm |
| 2018-08-03 | KATHLEEN P. BLOCH | Chief Financial Officer | Buy | 10,000.00 | 2.88 | 28,750.00 | 260,004.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418042396/0001144204-18-042396-index.htm |
| 2018-08-28 | KATHLEEN P. BLOCH | Chief Financial Officer | Buy | 10,000.00 | 2.88 | 28,750.00 | 260,004.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418047336/0001144204-18-047336-index.htm |
| 2019-12-10 | KATHLEEN P. BLOCH | Chief Financial Officer | Buy | 3,000.00 | 3.68 | 11,029.50 | 291,895.00 | https://www.sec.gov/Archives/edgar/data/1175151/000110465919071352/0001104659-19-071352-index.htm |
| 2019-07-22 | KATHLEEN P. BLOCH | Chief Financial Officer | Buy | 43,000.00 | 295,725.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420419035843/0001144204-19-035843-index.htm | ||
| 2019-05-10 | KATHLEEN P. BLOCH | Chief Financial Officer | Buy | 3,000.00 | 6.49 | 19,476.30 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420419025962/0001144204-19-025962-index.htm |
| 2018-06-14 | Capponi Vincent | Chief Operating Officer | Buy | 11,367.00 | 3.75 | 42,626.25 | 319,350.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418034653/0001144204-18-034653-index.htm |
| 2020-07-31 | KATHLEEN P. BLOCH | Chief Financial Officer | Buy | 10,000.00 | 5.60 | 56,000.00 | 325,156.00 | https://www.sec.gov/Archives/edgar/data/1175151/000110465920090308/0001104659-20-090308-index.htm |
| 2019-03-04 | Capponi Vincent | Chief Operating Officer | Buy | 4,620.00 | 325,435.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420419012637/0001144204-19-012637-index.htm | ||
| 2018-06-15 | Capponi Vincent | Chief Operating Officer | Buy | 8,633.00 | 3.75 | 32,373.75 | 327,983.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418034653/0001144204-18-034653-index.htm |
| 2020-02-28 | KATHLEEN P. BLOCH | Chief Financial Officer | Buy | 43,000.00 | 328,828.00 | https://www.sec.gov/Archives/edgar/data/1175151/000110465920028654/0001104659-20-028654-index.htm | ||
| 2018-08-02 | Capponi Vincent | Chief Operating Officer | Sell | 2,835.00 | 13.00 | 36,855.00 | 332,768.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418042169/0001144204-18-042169-index.htm |
| 2018-08-03 | Capponi Vincent | Chief Operating Officer | Sell | 7,600.00 | 13.08 | 99,408.00 | 332,768.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418042169/0001144204-18-042169-index.htm |
| 2018-08-28 | Capponi Vincent | Chief Operating Officer | Sell | 9,565.00 | 13.00 | 124,345.00 | 332,768.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418047340/0001144204-18-047340-index.htm |
| 2018-08-29 | Capponi Vincent | Chief Operating Officer | Sell | 20,000.00 | 14.00 | 280,000.00 | 332,768.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418047558/0001144204-18-047558-index.htm |
| 2018-08-02 | Capponi Vincent | Chief Operating Officer | Buy | 2,835.00 | 3.45 | 9,780.75 | 335,603.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418042169/0001144204-18-042169-index.htm |
| 2018-08-03 | Capponi Vincent | Chief Operating Officer | Buy | 7,600.00 | 3.45 | 26,220.00 | 340,368.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418042169/0001144204-18-042169-index.htm |
| 2019-03-04 | Eric R. Mortensen | Chief Medical Officer | Buy | 4,620.00 | 34,166.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420419012634/0001144204-19-012634-index.htm | ||
| 2018-08-28 | Capponi Vincent | Chief Operating Officer | Buy | 9,565.00 | 3.75 | 35,868.75 | 342,333.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418047340/0001144204-18-047340-index.htm |
| 2018-06-15 | Capponi Vincent | Chief Operating Officer | Sell | 8,633.00 | 12.00 | 103,596.00 | 347,983.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418034653/0001144204-18-034653-index.htm |
| 2018-08-29 | Capponi Vincent | Chief Operating Officer | Buy | 20,000.00 | 3.45 | 69,000.00 | 352,768.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418047558/0001144204-18-047558-index.htm |
| 2018-06-14 | Capponi Vincent | Chief Operating Officer | Sell | 11,367.00 | 12.00 | 136,404.00 | 356,616.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418034653/0001144204-18-034653-index.htm |
| 2018-06-15 | Capponi Vincent | Chief Operating Officer | Buy | 40,000.00 | 0.88 | 35,000.00 | 367,983.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418034653/0001144204-18-034653-index.htm |
| 2019-08-16 | Capponi Vincent | Chief Operating Officer | Buy | 4,600.00 | 4.33 | 19,895.00 | 372,501.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420419040420/0001144204-19-040420-index.htm |
| 2019-07-22 | Capponi Vincent | Chief Operating Officer | Buy | 54,100.00 | 376,322.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420419035842/0001144204-19-035842-index.htm | ||
| 2020-03-10 | Capponi Vincent | Chief Operating Officer | Buy | 6,500.00 | 3.45 | 22,425.00 | 417,649.00 | https://www.sec.gov/Archives/edgar/data/1175151/000110465920032715/0001104659-20-032715-index.htm |
| 2020-03-10 | Capponi Vincent | Chief Operating Officer | Sell | 4,677.00 | 6.00 | 28,062.00 | 417,649.00 | https://www.sec.gov/Archives/edgar/data/1175151/000110465920032715/0001104659-20-032715-index.htm |
| 2020-04-27 | Capponi Vincent | Chief Operating Officer | Sell | 10,000.00 | 10.00 | 100,000.00 | 417,649.00 | https://www.sec.gov/Archives/edgar/data/1175151/000110465920053381/0001104659-20-053381-index.htm |
| 2020-02-28 | Capponi Vincent | Chief Operating Officer | Buy | 54,100.00 | 420,849.00 | https://www.sec.gov/Archives/edgar/data/1175151/000110465920028657/0001104659-20-028657-index.htm | ||
| 2020-03-10 | Capponi Vincent | Chief Operating Officer | Buy | 4,677.00 | 3.45 | 16,135.65 | 422,326.00 | https://www.sec.gov/Archives/edgar/data/1175151/000110465920032715/0001104659-20-032715-index.htm |
| 2020-04-27 | Capponi Vincent | Chief Operating Officer | Buy | 10,000.00 | 2.88 | 28,750.00 | 427,649.00 | https://www.sec.gov/Archives/edgar/data/1175151/000110465920053381/0001104659-20-053381-index.htm |
| 2020-05-05 | Capponi Vincent | President and COO | Buy | 10,123.00 | 9.26 | 93,738.98 | 427,772.00 | https://www.sec.gov/Archives/edgar/data/1175151/000110465920058219/0001104659-20-058219-index.htm |
| 2019-03-04 | Phillip P. Chan | President and CEO | Buy | 5,500.00 | 431,149.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420419012636/0001144204-19-012636-index.htm | ||
| 2018-09-07 | Phillip P. Chan | President and CEO | Sell | 2,731.00 | 14.11 | 38,534.41 | 438,281.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418048704/0001144204-18-048704-index.htm |
| 2018-09-05 | Phillip P. Chan | President and CEO | Buy | 600.00 | 2.00 | 1,200.00 | 438,881.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418048704/0001144204-18-048704-index.htm |
| 2018-09-06 | Phillip P. Chan | President and CEO | Sell | 2,900.00 | 14.75 | 42,775.00 | 441,012.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418048704/0001144204-18-048704-index.htm |
| 2018-09-05 | Phillip P. Chan | President and CEO | Sell | 5,187.00 | 14.85 | 77,026.95 | 443,912.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418048704/0001144204-18-048704-index.htm |
| 2018-09-05 | Phillip P. Chan | President and CEO | Buy | 5,187.00 | 2.10 | 10,892.70 | 444,068.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418048704/0001144204-18-048704-index.htm |
| 2018-09-06 | Phillip P. Chan | President and CEO | Buy | 2,900.00 | 2.10 | 6,090.00 | 446,968.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418048704/0001144204-18-048704-index.htm |
| 2018-09-05 | Phillip P. Chan | President and CEO | Sell | 600.00 | 14.85 | 8,910.00 | 449,099.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418048704/0001144204-18-048704-index.htm |
| 2018-09-07 | Phillip P. Chan | President and CEO | Buy | 2,731.00 | 2.10 | 5,735.10 | 449,699.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418048704/0001144204-18-048704-index.htm |
| 2018-12-07 | Phillip P. Chan | President and CEO | Sell | 24,337.00 | 9.37 | 228,025.52 | 503,281.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418064025/0001144204-18-064025-index.htm |
| 2019-06-07 | Phillip P. Chan | President and CEO | Buy | 20,000.00 | 4.33 | 86,500.00 | 515,582.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420419030586/0001144204-19-030586-index.htm |
| 2018-12-07 | Phillip P. Chan | President and CEO | Buy | 89,337.00 | 2.10 | 187,607.70 | 527,618.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420418064025/0001144204-18-064025-index.htm |
| 2019-07-22 | Phillip P. Chan | President and CEO | Buy | 60,000.00 | 575,582.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420419035836/0001144204-19-035836-index.htm | ||
| 2019-08-15 | Phillip P. Chan | President and CEO | Buy | 75,000.00 | 3.45 | 258,750.00 | 641,188.00 | https://www.sec.gov/Archives/edgar/data/1175151/000114420419040629/0001144204-19-040629-index.htm |
| 2019-12-06 | Phillip P. Chan | President and CEO | Buy | 16,500.00 | 3.60 | 59,400.00 | 657,688.00 | https://www.sec.gov/Archives/edgar/data/1175151/000110465919070448/0001104659-19-070448-index.htm |
| 2020-02-28 | Phillip P. Chan | President and CEO | Buy | 60,000.00 | 711,178.00 | https://www.sec.gov/Archives/edgar/data/1175151/000110465920028648/0001104659-20-028648-index.htm | ||
| 2020-05-05 | Phillip P. Chan | Chief Executive Officer | Buy | 14,100.00 | 9.39 | 132,399.00 | 714,682.00 | https://www.sec.gov/Archives/edgar/data/1175151/000110465920058217/0001104659-20-058217-index.htm |
| 2020-08-18 | Edward Raymond Jones | Director | Buy | 4,000.00 | 3.35 | 13,400.00 | 78,800.00 | https://www.sec.gov/Archives/edgar/data/1175151/000110465920097228/0001104659-20-097228-index.htm |